Review: eradication of Helicobacter pylori. Problems and recommendations (Q39453816)

12 September 2017

1 reference

title

Review: eradication of Helicobacter pylori. Problems and recommendations (English)

1 reference

12 September 2017

0 references

Huang JQ

1

1 reference

12 September 2017

Hunt RH

series ordinal

2

1 reference

12 September 2017

publication date

1 August 1997

1 reference

Journal of Gastroenterology and Hepatology

12 September 2017

published in

1 reference

12 September 2017

volume

12

1 reference

12 September 2017

issue

8

1 reference

12 September 2017

page(s)

590-598

1 reference

Eradication of Helicobacter pylori infection

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Treatment of Helicobacter pylori infection: a review of the world literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Testing for Helicobacter pylori in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Helicobacter pylori infection and the risk for duodenal and gastric ulceration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Costs of duodenal ulcer therapy with antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Helicobacter pylori: the place of the new macrolides in the eradication of the bacteria in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Pharmacological aspects of acid secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00491.X

10.1111/J.1440-1746.1997.TB00491.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference